Skip to main content
Premium Trial:

Request an Annual Quote

Cancer's Clues

In a Business Report: The [San Francisco] Chronicle with Bloomberg post, John Lauerman says that "using faster, more accurate technologies, doctors are combing through ever-wider swaths of the human genome to pinpoint and counteract the causes of disease." According to the Dana-Farber Cancer Institute's Barrett Rollins, "cancer is among the most promising targets." Rollins tells Lauerman that genome screens are quickly becoming standard tests in the community, and adds, "if you're working at a cancer center and not thinking about this, you should be fired."

Bloomberg's Lauerman, a participant in the Personal Genome Project led by Harvard's George Church, says that while he "waited to see what my genome can reveal about my future health, I thought about whether I might face a heightened risk of cancer." Business Report adds that Lauerman's sequencing results will be detailed in future posts.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.